["{\"step_by_step_thinking\": \"Based on the provided documents, we can see that Ocusert is a drug application method that releases a low concentration of a substance continuously and with a constant rate. Acetazolamid (Diamox) has been shown to be effective in long-term treatment at much lower concentrations than usual. Clonidine is mentioned as a sympatholytic agent that can reduce intraocular pressure, but its pressure-lowering mechanism is not quite clarified yet. Guanethidine is also mentioned as a valuable agent for reducing intraocular pressure in special cases. Beta-receptor-blocking agents like Propranolol could become important, and chemical sympathectomy by 6-Hydroxydopamine might be useful for certain indications.\n\nIn terms of surgery, the document discusses a variant that enhances outflow of aqueous fluid from the anterior chamber into suprachoroidal and subconjunctival spaces, resulting in a reliable and stable hypotensive effect. This suggests that surgical options are available for reducing intraocular pressure in glaucoma patients.\n\nFinally, the documents mention problems related to intraocular pressure and early primary open-angle glaucoma, which highlights the importance of monitoring and managing intraocular pressure to prevent vision loss. The document on cataract surgery with intraocular lens implantation discusses the challenges of controlling intraocular pressure after surgery and mentions the use of Argon laser trabeculoplasty (ALT) as a treatment option.\n\nBased on this information, we can conclude that...\", \"answer_choice\": C}"]